Japan vs New Zealand: Number of isolates tested for extended-spectrum cephalosporins
Japan
692
in 2018
New Zealand
456
in 2017
Japan rank
7th
New Zealand rank
8th
Number of isolates tested for extended-spectrum cephalosporins over time
- Japan
- New Zealand
How they compare
Japan currently reports 692 against 456 in New Zealand, a difference of 236.
That makes Japan's figure about 1.5 times New Zealand's.
The two have swapped places 4 times across 9 shared years of data; in 2009 it was Japan ahead.
Japan ranks 7th and New Zealand ranks 8th of 51 countries.
Across the 2 decades both report, Japan averaged higher in 1 and New Zealand in 1.
Head to head by decade
| Decade | Japan | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 403 | 234 | 169 | Japan |
| 2010s | 377.25 | 389.38 | 12.12 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for extended-spectrum cephalosporins, Japan or New Zealand?
- Japan, at 692 against 456 in New Zealand as of 2018.
- What is the difference in number of isolates tested for extended-spectrum cephalosporins between Japan and New Zealand?
- 236, with Japan ahead.
- How many years of comparable data are there for Japan and New Zealand?
- 9 years are reported by both, from 2009 to 2017.
- How do Japan and New Zealand rank globally for number of isolates tested for extended-spectrum cephalosporins?
- Japan ranks 7th and New Zealand ranks 8th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for extended-spectrum cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.